AstraZeneca Urges “Basket” Approach To Rx Pricing Debate
Executive Summary
Average U.S. drug prices across a "basket" of products are not significantly different than other markets, AstraZeneca CEO Tom McKillop maintained during an investor business review in Wilmington, Del. Oct. 2